Cecile Herate
Overview
Explore the profile of Cecile Herate including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
295
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aguilar J, Akbar S, Al-Mahtab M, Khan M, Guzman C, Fernandez G, et al.
Euroasian J Hepatogastroenterol
. 2025 Jan;
14(2):221-237.
PMID: 39802853
How To Cite This Article: Aguilar JC, Akbar SMF, Al-Mahtab M, HeberNasvac: Development and Application in the Context of Chronic Hepatitis B. Euroasian J Hepato-Gastroenterol 2024;14(2):221-237.
2.
Bhatt U, Herate C, Estelien R, Relouzat F, Dereuddre-Bosquet N, Maciorowski D, et al.
Vaccines (Basel)
. 2024 Aug;
12(8).
PMID: 39204008
PARVAX is a genetic vaccine platform based on an adeno-associated vector that has demonstrated to elicit potent, durable, and protective immunity in nonhuman primates (NHPs) after a single dose. Here,...
3.
Fenwick C, Turelli P, Duhoo Y, Lau K, Herate C, Marlin R, et al.
J Infect
. 2023 Oct;
87(6):524-537.
PMID: 37852477
Objectives: Due to the rapid evolution of SARS-CoV-2 to variants with reduced sensitivity to vaccine-induced humoral immunity and the near complete loss of protective efficacy of licensed therapeutic monoclonal antibodies,...
4.
Marc A, Marlin R, Donati F, Prague M, Kerioui M, Herate C, et al.
PLoS Comput Biol
. 2023 Aug;
19(8):e1010721.
PMID: 37556476
The impact of variants of concern (VoC) on SARS-CoV-2 viral dynamics remains poorly understood and essentially relies on observational studies subject to various sorts of biases. In contrast, experimental models...
5.
Hermet P, Delache B, Herate C, Wolf E, Kivi G, Juronen E, et al.
PLoS Pathog
. 2023 Aug;
19(8):e1011532.
PMID: 37531329
The COVID-19 pandemic represents a global challenge that has impacted and is expected to continue to impact the lives and health of people across the world for the foreseeable future....
6.
Herate C, Marlin R, Touret F, Dereuddre-Bosquet N, Donati F, Relouzat F, et al.
Heliyon
. 2023 Jun;
9(6):e16664.
PMID: 37287613
The SARS-CoV2 Omicron variants have acquired new Spike mutations leading to escape from the most of the currently available monoclonal antibody treatments reducing the options for patients suffering from severe...
7.
SARS-CoV-2-related bat virus behavior in human-relevant models sheds light on the origin of COVID-19
Temmam S, Montagutelli X, Herate C, Donati F, Regnault B, Attia M, et al.
EMBO Rep
. 2023 Mar;
24(4):e56055.
PMID: 36876574
Bat sarbecovirus BANAL-236 is highly related to SARS-CoV-2 and infects human cells, albeit lacking the furin cleavage site in its spike protein. BANAL-236 replicates efficiently and pauci-symptomatically in humanized mice...
8.
Fenwick C, Turelli P, Ni D, Perez L, Lau K, Herate C, et al.
Nat Microbiol
. 2022 Jul;
7(9):1376-1389.
PMID: 35879526
The SARS-CoV-2 Omicron variant has very high levels of transmission, is resistant to neutralization by authorized therapeutic human monoclonal antibodies (mAb) and is less sensitive to vaccine-mediated immunity. To provide...
9.
Zabaleta N, Bhatt U, Herate C, Maisonnasse P, Sanmiguel J, Diop C, et al.
Mol Ther
. 2022 May;
30(9):2952-2967.
PMID: 35546782
The COVID-19 pandemic continues to have devastating consequences on health and economy, even after the approval of safe and effective vaccines. Waning immunity, the emergence of variants of concern, breakthrough...
10.
Naninck T, Kahlaoui N, Lemaitre J, Maisonnasse P, De Mori A, Pascal Q, et al.
iScience
. 2022 Mar;
25(4):104101.
PMID: 35313622
Non-human primates (NHPs) are particularly relevant as preclinical models for SARS-CoV-2 infection and nuclear imaging may represent a valuable tool for monitoring infection in this species. We investigated the benefit...